Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
94 studies found for:    "ACDC"
Show Display Options
Rank Status Study
21 Unknown  Plasma Adiponectin Concentration, Activity and Isoforms in Newly Diagnosed and Untreated Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus
Intervention:
22 Completed Effect of High Protein Diet on Adiponectin and Inflammation Among Overweight and Obese Children
Conditions: Body Mass Index Quantitative Trait Locus 5 Disorder;   Tangier Disease
Intervention: Other: nutrition intervention
23 Completed Effects of Legume Consumption on Adiponectin and Inflammatory Markers Among Adults
Condition: Diabetes Mellitus, Type 2
Interventions: Other: nutritional intervention;   Other: life style intervention
24 Completed Effect of Selenium on Serum Adiponectin, Homocystein and Malnutrition-inflammation Complex Syndrome in Hemodialysis Patients
Conditions: Oxidative Stress;   Inflammation;   Malnutrition
Interventions: Dietary Supplement: Selenium Supplement;   Other: placebo
25 Unknown  Effect of Different Hemodialysis Modality on Adiponectin,Vascular Function and Clinical Prognosis
Condition: End-Stage Renal Disease
Intervention: Device: conventional artificial kidney (AK) vs. high flux AK
26 Completed Relation Between Renin-Angiotensin Gene Polymorphisms, Plasma Adiponectin and Arterial Stiffness in Renal Transplant Recipients
Conditions: Vascular Diseases;   Arterial Stiffness
Intervention:
27 Active, not recruiting Assessment of Endothelial Function, Apolipoproteins and Adiponectin Levels as Markers of Cardiovascular Before and After Liver Transplantation
Condition: Cirrhosis
Intervention:
28 Completed HMW-Adiponectin is Raised in Newborns
Condition: Pre-Eclampsia
Intervention:
29 Completed Melatonin and Adiponectin in Hypertensive Kidney Transplant
Conditions: Hypertension;   Kidney Transplant
Intervention:
30 Completed Recombinant Human Erythropoietin Dose, Serum Adiponectin, and All-Cause Mortality in Patients Beginning Hemodialysis
Condition: Hemodialysis
Intervention:
31 Terminated Study of the Relationship Between rHuEPO Dose, Serum ADPN, and Mortality in Patients Beginning HD
Condition: Renal Dialysis
Intervention:
32 Completed Study of the Relationship Between rHuEPO Dose, Serum ADPN, and Mortality in Patients Beginning Hemodialysis (HD)
Condition: Renal Dialysis
Intervention:
33 Completed The Role of Leptin Receptors in NASH
Conditions: Nonalcoholic Steatohepatitis;   Metabolic Syndrome
Intervention: Other: no interventions, only regular blood-draw
34 Enrolling by invitation The Effect of n-3 Fatty Acid Supplementation on Serum Levels, and Gene Expression of type2 Diabetes Patient
Condition: Diabetes Mellitus Type II
Interventions: Dietary Supplement: n-3 Fatty Acid;   Dietary Supplement: Placebo
35 Unknown  Arterial Closure Device Comparison Trial II – ACDC Trial II
Condition: Arterial Hemostasis After Coronary Intervention
Intervention: Device: closure device placement
36 Completed Arterial Closure vs Direct Compression for Hemostasis After PCI - The ACDC Trial
Conditions: Coronary Angioplasty;   Coronary Artery Disease
Interventions: Procedure: Closure Device;   Procedure: Direct Compression
37 Unknown  Adiponectin Gene and Coronary Artery Disease
Condition: Coronary Artery Disease
Intervention:
38 Completed Simvastatin Reduces Adiponectin Levels and Insulin Sensitivity
Condition: Hypercholesterolemia
Intervention:
39 Completed Plasma Adiponectin Levels and Relations With Cytokines in Children With Acute Rheumatic Fever
Condition: Acute Rheumatic Fever
Intervention:
40 Completed Effect of Adiponectin Genetic Polymorphism on Rosiglitazone Response
Condition: Diabetes Mellitus
Intervention: Drug: rosiglitazone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years